These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12488942)

  • 1. Schizophrenia in males of cognitive performance: discriminative and diagnostic values.
    Camozzato A; Chaves ML
    Rev Saude Publica; 2002 Dec; 36(6):743-8. PubMed ID: 12488942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls?
    Ojeda N; Sánchez P; Peña J; Elizagárate E; Yoller AB; Larumbe J; Gutiérrez M; Casais L; Ezcurra J
    J Nerv Ment Dis; 2010 Apr; 198(4):286-91. PubMed ID: 20386258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
    Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
    Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontal lobe cognition disorders in 42 schizophrenic patients compared with 19 normal probands].
    Jaquet I; Lançon C; Auquier P; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):34-41. PubMed ID: 9172966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong.
    Chen EY; Lam LC; Chen RY; Nguyen DG; Chan CK
    Acta Psychiatr Scand; 1996 Feb; 93(2):144-50. PubMed ID: 8686485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive functioning in schizophrenia: Unique and shared variance with measures of fluid intelligence.
    Martin AK; Mowry B; Reutens D; Robinson GA
    Brain Cogn; 2015 Oct; 99():57-67. PubMed ID: 26263380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive substrates of thought disorder, I: the semantic system.
    Goldberg TE; Aloia MS; Gourovitch ML; Missar D; Pickar D; Weinberger DR
    Am J Psychiatry; 1998 Dec; 155(12):1671-6. PubMed ID: 9842774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fronto-temporal function may distinguish bipolar disorder from schizophrenia.
    Frangou S; Dakhil N; Landau S; Kumari V
    Bipolar Disord; 2006 Feb; 8(1):47-55. PubMed ID: 16411980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal studies of cognition in schizophrenia: meta-analysis.
    Szöke A; Trandafir A; Dupont ME; Méary A; Schürhoff F; Leboyer M
    Br J Psychiatry; 2008 Apr; 192(4):248-57. PubMed ID: 18378982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderator variables of executive functioning in schizophrenia: meta-analytic findings.
    Johnson-Selfridge M; Zalewski C
    Schizophr Bull; 2001; 27(2):305-16. PubMed ID: 11354597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in schizophrenia across age groups: a case-control study.
    Mosiołek A; Gierus J; Koweszko T; Szulc A
    BMC Psychiatry; 2016 Feb; 16():37. PubMed ID: 26908293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia.
    Mohr F; Hubmann W; Albus M; Franz U; Hecht S; Scherer J; Binder J; Sobizack N
    Psychiatry Res; 2003 Nov; 121(1):21-30. PubMed ID: 14572621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function in schizophrenia: association with negative and positive symptoms.
    Capleton RA
    Psychol Rep; 1996 Feb; 78(1):123-8. PubMed ID: 8839306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recognition of facial emotions and theory of mind in schizophrenia: could the theory of mind deficit be due to the non-recognition of facial emotions?].
    Besche-Richard C; Bourrin-Tisseron A; Olivier M; Cuervo-Lombard CV; Limosin F
    Encephale; 2012 Jun; 38(3):241-7. PubMed ID: 22726412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The language of schizophrenia: an analysis of micro and macrolinguistic abilities and their neuropsychological correlates.
    Marini A; Spoletini I; Rubino IA; Ciuffa M; Bria P; Martinotti G; Banfi G; Boccascino R; Strom P; Siracusano A; Caltagirone C; Spalletta G
    Schizophr Res; 2008 Oct; 105(1-3):144-55. PubMed ID: 18768300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.